|
hepatic steatosis inducing agent
|
CHEBI_83612 |
|
|
hepatotoxic agent
|
CHEBI_50908 |
|
|
lung carcinoma in situ
|
DOID_8800 |
|
|
intermediate coronary syndrome
|
DOID_8805 |
|
|
skin of body
|
UBERON_0002097 |
|
|
polyneuropathy
|
DOID_1389 |
|
|
Tangier disease
|
DOID_1388 |
|
|
hypolipoproteinemia
|
DOID_1387 |
|
|
abetalipoproteinemia
|
DOID_1386 |
|
|
Hedgehog signaling pathway inhibitor
|
CHEBI_140921 |
|
|
Fox-Fordyce disease
|
DOID_1381 |
|
|
glioma-associated oncogene inhibitor
|
CHEBI_140922 |
|
|
Grignard reagent
|
CHEBI_51237 |
|
|
kappa-opioid receptor antagonist
|
CHEBI_167165 |
|
|
urinary schistosomiasis
|
DOID_1394 |
|
|
plasma membrane
|
GO_0005886 |
|
|
pseudopapilledema
|
DOID_1392 |
|
|
Norum disease
|
DOID_1391 |
|
|
hypobetalipoproteinemia
|
DOID_1390 |
|
|
Geobacillus stearothermophilus
|
NCBITaxon_1422 |
|
